PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $86.92 million. The enterprise value is $39.12 million.
| Market Cap | 86.92M |
| Enterprise Value | 39.12M |
Important Dates
The last earnings date was Monday, April 15, 2024, before market open.
| Earnings Date | Apr 15, 2024 |
| Ex-Dividend Date | Aug 11, 2023 |
Share Statistics
PetMed Express has 21.15 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Shares Outstanding | 21.15M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | -1.71% |
| Owned by Insiders (%) | 4.42% |
| Owned by Institutions (%) | 74.97% |
| Float | 18.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 80.59 |
| PS Ratio | 0.31 |
| Forward PS | 0.29 |
| PB Ratio | 0.87 |
| P/FCF Ratio | 50.39 |
| PEG Ratio | 2.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.95, with an EV/FCF ratio of 22.68.
| EV / Earnings | n/a |
| EV / Sales | 0.14 |
| EV / EBITDA | 12.95 |
| EV / EBIT | n/a |
| EV / FCF | 22.68 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.32 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.54 |
| Debt / FCF | 0.95 |
| Interest Coverage | 3.94 |
Financial Efficiency
Return on equity (ROE) is -2.50% and return on invested capital (ROIC) is -4.46%.
| Return on Equity (ROE) | -2.50% |
| Return on Assets (ROA) | -1.60% |
| Return on Capital (ROIC) | -4.46% |
| Revenue Per Employee | $917,109 |
| Profits Per Employee | -$8,821 |
| Employee Count | 302 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 6.99 |
Taxes
In the past 12 months, PetMed Express has paid $324,000 in taxes.
| Income Tax | 324,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.35% in the last 52 weeks. The beta is 0.70, so PetMed Express's price volatility has been lower than the market average.
| Beta (1Y) | 0.70 |
| 52-Week Price Change | -73.35% |
| 50-Day Moving Average | 4.87 |
| 200-Day Moving Average | 8.44 |
| Relative Strength Index (RSI) | 27.91 |
| Average Volume (30 Days) | 393,753 |
Short Selling Information
The latest short interest is 4.90 million, so 23.17% of the outstanding shares have been sold short.
| Short Interest | 4.90M |
| Short Previous Month | 5.35M |
| Short % of Shares Out | 23.17% |
| Short % of Float | 27.04% |
| Short Ratio (days to cover) | 14.32 |
Income Statement
In the last 12 months, PetMed Express had revenue of $276.97 million and -$2.66 million in losses. Loss per share was -$0.14.
| Revenue | 276.97M |
| Gross Profit | 77.85M |
| Operating Income | -4.54M |
| Pretax Income | -2.34M |
| Net Income | -2.66M |
| EBITDA | 3.02M |
| EBIT | -3.14M |
| Loss Per Share | -$0.14 |
Balance Sheet
The company has $49.44 million in cash and $1.64 million in debt, giving a net cash position of $47.80 million or $2.26 per share.
| Cash & Cash Equivalents | 49.44M |
| Total Debt | 1.64M |
| Net Cash | 47.80M |
| Net Cash Per Share | $2.26 |
| Equity / Book Value | 100.06M |
| Book Value Per Share | 4.73 |
| Working Capital | 23.15M |
Cash Flow
In the last 12 months, operating cash flow was $6.92 million and capital expenditures -$5.19 million, giving a free cash flow of $1.73 million.
| Operating Cash Flow | 6.92M |
| Capital Expenditures | -5.19M |
| Free Cash Flow | 1.73M |
| FCF Per Share | $0.08 |
Margins
Gross margin is 28.11%, with operating and profit margins of -1.64% and -0.96%.
| Gross Margin | 28.11% |
| Operating Margin | -1.64% |
| Pretax Margin | -0.84% |
| Profit Margin | -0.96% |
| EBITDA Margin | 1.09% |
| EBIT Margin | -1.13% |
| FCF Margin | 0.62% |
Dividends & Yields
This stock pays an annual dividend of $0.60, which amounts to a dividend yield of 14.60%.
| Dividend Per Share | $0.60 |
| Dividend Yield | 14.60% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | 13.99% |
| Earnings Yield | -3.06% |
| FCF Yield | 1.98% |
Analyst Forecast
The average price target for PetMed Express is $13.25, which is 222.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.25 |
| Price Target Difference | 222.38% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 3.03 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.03 |
| Piotroski F-Score | 4 |